Document is current
Any future updates will be listed below
-
Authors
Williamson, Rachel D.
McCarthy, Fergus P.
Kenny, Louise C.
McCarthy, Cathal M.
-
Funding
Funding for this research was provided by:
Health Research Board (HRA-POR-2015-1240, HRA-POR-2015-1240, HRA-POR-2015-1240)
Science Foundation Ireland (12/RC/2272)
- License Information
-
More Information
Article History
Received: 12 November 2018
Accepted: 18 March 2019
First Online: 11 April 2019
Competing Interests
: L.C. Kenny is a minority shareholder in Metabolomic Diagnostics, a campus-based spin-out that has licensed technology concerning the use of metabolomics biomarkers in the prediction of preeclampsia.
